Company intelligence / Profile preview

Nevagen

Sacramento (HQ), California, United States

Ownership: Private
Development stage: Other

Overview

Nivagen develops, manufactures, and markets generic and specialty pharmaceutical products—including sterile injectables and oral solids—with over 32 ANDAs marketed and more than 25 injectables and 505(b)(2) products at various development stages[1][2][4].

Modalities: Small moleculeSterile injectableBiologic505(b)(2) drug
Industry: Biotech

Partnerships

AI formulation company for long-acting injectable including GLP1 (as of 2024–2025)

Beyond the preview

Go deeper on Nevagen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nevagen.

Explore the full profile